Radiculopathy clinical trial scenario

“Radiculopathy Global Clinical Trials Review, H1, 2013" provides data on the Radiculopathy clinical trial scenario. This provides elemental information and data relating to the clinical trials on Radiculopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Radiculopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by  team of industry experts.

To Know More :   Radiculopathy  Global  Clinical  Trials  Review

Opportunities in US Blood Banking Market

Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues.Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, hospitals, commercial laboratories, and plasma fractionation facilities.Annual placements and installed base estimates for major automated and semiautomated analyzers.Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.Ten-year reagent and instrument sales forecasts.Sales and market shares of leading reagent and instrument suppliers.Review of current and emerging technologies, and their potential market applications.
Product development opportunities for instruments ,consumables, and auxiliary products.Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Business opportunities and strategic recommendations for suppliers.
To Know More : Blood Banking Market

The Global Market for Pain Management Drugs and Devices

The Global Market for Pain Management Drugs and Devices, provides an overview of products included in this market, and detailed analyses of markets and competitive environments. The study includes information about significant products, players, issues and trends, regulatory issues, and other information affecting the pain management industry.This study will provide the reader with the knowledge to adequately view and assess pain management and the problems that the healthcare industry faces as well as provide insights into the market potentials. This covers a wide variety of treatments and products that many people worldwide rely on.This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global with a U.S. emphasis. This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts, and competitive analyses.
To Know More :  Pain Management Drugs and Devices Market

In-depth analysis of the global remote patient monitoring market

“Remote Patient Monitoring Market to 2019 - Potential to Reduce Healthcare Cost Burden and Improve Quality of Care to Drive Future Growth” looks at the market, competitive landscape, and trends for the two remote patient monitoring market segments: implantable remote patient monitoring and external remote patient monitoring. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
To Know More : Remote Patient Monitoring Market

Healthcare Building Construction in Portugal

'Healthcare Building Construction in Portugal to 2017: Market Databook' contains detailed historic and forecast market value data for the healthcare buildings construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods.This report is the result of extensive market research covering the healthcare buildings construction industry in Portugal. It contains detailed historic and forecast market value data for the healthcare buildings construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Healthcare Building Construction in Portugal to 2017: Market Databook' provides a top-level overview and detailed insight into the operating environment of the healthcare buildings construction industry in Portugal. It is an essential tool for companies active across the Portuguese construction value chain and for new players considering to enter the market.
To Know More : Healthcare Building Construction in Portugal

Healthcare Insurance in Estonia

'Healthcare Insurance in Estonia to 2017: Market Databook' contains detailed historic and forecast data covering healthcare insurance in the personal accident and health insurance industry in Estonia. This databook provides data on gross written premiums, earned premiums, number of active policies, number of schemes offered, penetration percentage, gross claims, paid claims, change in outstanding reserves, incurred loss and loss ratio percentage.

To Know More : Healthcare Insurance in Estonia

Analgesics in Australia

Arthritis was a key driver of sales within analgesics in 2012. A report by Access Economics found that 3.85 million Australians suffer with a form of arthritis, with the figure expected to double by 2050. With Australians worried about developing arthritis more than any other disease, brand operators have focused on developing more effective products for the relief of arthritic pain.
To Know More : Analgesics in Australia

Refurbished Imaging Medical Equipment Market in India

Refurbished Imaging Medical Equipment market has witnessed a healthy growth in the recent past and will continue to do so in coming years. Lower cost of refurbished equipments and increasing occurrence of lifestyle diseases are the major drivers for the growth of refurbished imaging equipments.In the next section market characteristics of refurbished imaging medical equipments has been listed. This section explains how refurbished equipments lead to quick return on investments. At the same time doctors express serious concern over quality of refurbished equipments which might affect the treatment quality. Patients might be adversely affected. Sometimes refurbished equipments suffer from poor after sales service resulting in disruption of services. Rapid technology up-gradation has also resulted in the growth of refurbished equipments in India. Hospitals prefer to buy refurbished equipment as they get a relatively new machine at a fraction of the price. Moreover people are sometimes unaware whether the device is new or refurbished and they are driven only by price-has also resulted in the growth of refurbished imaging medical equipment.

To Know More : Refurbished Imaging Medical Equipment Market in India

Health and Beauty Specialist Retailers

The Spanish economic crisis and its consequences, specifically record unemployment levels and high public deficit contributed to the poor performance of health and beauty specialist retailers during 2012 as the channel declined in value by 8%. The unemployment rate in Spain had climbed to 24% by the end of 2012, and it remains unclear as to when this figure might fall.



To Know More : Health and Beauty Specialist Retailers 

Japanese orthopedic large joint reconstruction device market is expected to exceed $2.3 billion over the 2012–2019

The Japanese Orthopedic large joint reconstruction device market is expected to exceed $2.3 billion over the 2012–2019 forecast period. The orthopedic large joint reconstruction device market includes hip and knee implants, as well as bone cements used to help adhere the implants to bone. Demand is increasing for large joint arthroplasty, which is attributed to the aging Japanese population and a higher number of highly active individuals. Procedure growth will rise again over the forecast period as patients are no longer able to postpone the elective joint replacement procedure.

To Know More : Japanese Market for Orthopedic Large Joint Reconstruction Devices

Global Flow Cytometry market to grow at a CAGR of 10.82 percent over the period 2012-2016

The Global Flow Cytometry market to grow at a CAGR of 10.82 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in technological advancements. The Global Flow Cytometry market has also been witnessing the trend of an increase in market consolidation. However, the intense competition among the vendors could pose a challenge to the growth of this market.

To Know More : Global Flow Cytometry Market 2012-2016

The Canadian endoscopic and surgical devices Market was valued at over $475 million in 2012

In 2012, the Canadian endoscopic and surgical devices Market was valued at over $475 million. High demand for GI screening and intervention procedures due to the aging population and growing awareness will drive market growth. Many segments of the Canadian market are dominated by group purchasing organizations (GPOs) that issue large scale tenders, often to cover all the hospitals in a province. Growth can be attributed to advances in technology, such as the recent adaptation of HD technology, as well as a trend among specialists and patients to opt for minimally invasive surgery. 

To Know More - Canadian Endoscopic and Surgical Devices Market

Animal Health products is expected to rise 3.9 percent annually to almost $13 billion in 2016

US demand to approach $13 billion in 2016
US demand for animal health products is expected to rise 3.9 percent annually to almost $13 billion in 2016. Gains in all product segments will be at least incrementally improved from those during the recession-impacted 2006-2011 period. Preventive care will remain a driving factor in sales of animal health products as owners of commercial and companion animals alike recognize the need to maintain good health conditions for their animals. Commercial animals, including livestock and poultry, are largely intended to enter the human food chain, making prevention and eradication of disease a vital ongoing concern for both animal and human health. Furthermore, as pet owners increasingly treat their companion animals as members of the family, pets’ lifespans will continue to lengthen, driving strong sales of health products.  

To Know More - Animal Health Chemicals to 2016

Global ENT Devices market to grow at a CAGR of 7.37 percent over the period 2012-2016

Global ENT Devices market to grow at a CAGR of 7.37 percent over the period 2012-2016. One of the key factors contributing to this market growth is the advancements in the Cochlear Implant Devices segment. The Global ENT Devices market has also been witnessing an increase in the number of acquisitions and new entrants. However, problems with voice prosthesis and hearing aid device batteries could pose a challenge to the growth of this market.
 
To Know More -  Global ENT Devices Market 2012-2016

The Value of The Global Therapeutic Respiratory Devices Market in 2012 will reach $4.5bn

The Medical device industry has witnessed explosive growth in recent years. the global market was worth $266.0bn in 2011. Much of this growth is linked to the rising prevalence of a number of diseases worldwide; most notably in cardiac and neurological systems. After the negative effects the recession had on healthcare budgets in 2009, the medical device industry began to recover owing to patient demographics, physician adoption and patient demand. The medical device industry is one of the largest and fastest growing areas of the medical and pharmaceutical industries.

To Know More - Therapeutic Respiratory Devices: Global Market Outlook 2012-2022

The Total Advanced Wound Care Market to be worth $16.3bn in 2023

The demand for advanced wound care products is expected to rise over the next 10 years, driven by an increase in chronic wounds. This can be attributed to an aging population and an increase in lifestyle related disorders such as diabetes and obesity. predicts the total advanced wound care market to be worth $16.3bn in 2023.  The move from traditional wound care treatment to advanced wound care started in the mid 80's, with more and more advanced products coming in to the market. Clinicians and patients now prefer advanced wound care products over traditional products, as they are more efficient in wound healing and reduce hospital stays. While moist wound care products currently dominate the market, wound care devices and biologics are witnessing strong growth. More companies, both multinationals and smaller companies are investing in R&D to make their product lines stronger. However, the growth will depend on more clinical evidence becoming available.
 

To Know More - Advanced Wound Care: World Market Prospects 2013-2023

Pet Health Products and Services at the consumer level is expected to reach $31.7 billion in 2016

Consumer spending on pets to reach $31.7 billion in 2016
US spending on pet health products and services at the consumer level is expected to reach $31.7 billion in 2016. Manufacturers’ level pet health product demand is forecast to increase 4.6 percent annually to $5.6 billion that year. Advances in expenditures will be encouraged by the continuing trend of humanizing companion animals and their perception as family members, as well as by growth in the overall pet population. Veterinary technology will continue to adapt diagnostic and treatment techniques from human health care, stimulating value gains for newer, more costly procedures.  While the US pet health industry has traditionally been regarded as being “recession-resistant,” spending was somewhat impacted by the 2007-2009 US economic recession. However, demand did not experience declines during this time, as health care is a necessary -- and, to some degree, expected -- expenditure for pet owning households.
 
To Know More - Pet Health: Products & Service

Revenues for the Elder Care services industry (i.e., skilled nursing, home health care, social services, continuing care, and assisted living) are expected to grow 5.2 percent per year through 2016 to $319.5 billion

US revenues to grow 5.2% annually through 2016
Revenues for the Elder care services industry (i.e., skilled nursing, home health care, social services, continuing care, and assisted living) are expected to grow 5.2 percent per year through 2016 to $319.5 billion. Advances will be driven largely by demographic changes in light of increasing life expectancy, which is contributing to the rising number of individuals in the older population segments. Growth is further boosted by the large, post-World War II “baby boom” generation entering their retirement years.

  To Know More - Elder Care Services to 2016

Brazil Healthcare spending in the country is also anticipated to grow at a CAGR of around 8.6% during 2012-2015

Brazil is considered as one of the most lucrative healthcare market in Latin America with highest healthcare expenditure. Strong government support and high healthcare services demand are some of the major factors propelling the country’s healthcare market to grow at a fast pace. The Brazilian Government has adopted several initiatives and implemented proper plans and policies that resulted in positive development of the overall healthcare services and facilities. Healthcare spending in the country is also anticipated to grow at a CAGR of around 8.6% during 2012-2015

To Know More - Brazil Healthcare - New Opportunities for Growth

The Total European Wound and Tissue Management Market Was Valued At €3.46 Billion In 2011

The European wound and tissue management market includes moist, antimicrobial and interactive wound dressings; negative pressure wound therapy, bandages, wound closure devices, hemostats, tissue sealants, and anti-adhesion products. These products treat a variety of wounds including surgical incisions, burns, and ulcers. The European wound and tissue management market is expected to be driven by an aging population and rising rates of diabetes, obesity, and heart disease. These chronic health problems create diabetic ulcers, venous leg ulcers, and major surgeries which drive both the wound management and wound closure segments of the market. Technological developments such as negative pressure wound therapy and skin substitutes are also driving the market.

To Know More - European Wound and Tissue Management Market

Indian Fitness & Slimming Industry Currently Pegged At USD 0.78 Billion Is Stated To Grow At a CAGR Of 25% To Reach USD 2.4 Billion By 2015.

Indian Fitness & Slimming Industry constitutes about 8% of the wellness market. Presently, the fitness industry is in its nascent stages. The industry is fairly fragmented since the majority of the market appears to be dominated by a large number of mom-and-pop gyms. Organized fitness services account for merely 25% of the overall fitness industry. Indian fitness & slimming industry currently pegged at USD 0.78 billion is stated to grow at a CAGR of 25% to reach USD 2.4 Billion by 2015. We would not be surprised if the industry outperforms our ballpark figure.

To Know More - Fitness & Slimming Industry In India